MXPA01003285A

MXPA01003285A -

Info

Publication number: MXPA01003285A
Authority: MX; Mexico
Prior art keywords: leptin; level; obese; individual; levels
Prior art date: 2001-03-29

Application number

MXPA/A/2001/003285A

Other languages

English (en)

Spanish (es)

Original Assignee

Amgen Inc

Filing date

2001-03-29

Publication date

2002-05-09

2001-03-29 Application filed by Amgen Inc filed Critical Amgen Inc

2002-05-09 Publication of MXPA01003285A publication Critical patent/MXPA01003285A/xx

Links

NRYBAZVQPHGZNS-ZSOCWYAHSA-N Leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims description 223
102000016267 Leptin Human genes 0.000 claims description 222
108010092277 Leptin Proteins 0.000 claims description 222
229940039781 leptin Drugs 0.000 claims description 193
210000002966 Serum Anatomy 0.000 claims description 43
108090001123 antibodies Proteins 0.000 claims description 16
102000004965 antibodies Human genes 0.000 claims description 16
230000004044 response Effects 0.000 claims description 10
235000001014 amino acid Nutrition 0.000 description 44
150000001413 amino acids Chemical class 0.000 description 39
241000282414 Homo sapiens Species 0.000 description 28
239000000203 mixture Substances 0.000 description 22
230000004580 weight loss Effects 0.000 description 22
102000004169 proteins and genes Human genes 0.000 description 20
108090000623 proteins and genes Proteins 0.000 description 20
235000018102 proteins Nutrition 0.000 description 19
230000001225 therapeutic Effects 0.000 description 13
210000004369 Blood Anatomy 0.000 description 12
239000008280 blood Substances 0.000 description 12
241000282412 Homo Species 0.000 description 10
241000700159 Rattus Species 0.000 description 10
125000003275 alpha amino acid group Chemical group 0.000 description 10
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
230000035945 sensitivity Effects 0.000 description 10
206010012601 Diabetes mellitus Diseases 0.000 description 9
230000000694 effects Effects 0.000 description 9
208000008589 Obesity Diseases 0.000 description 8
239000003814 drug Substances 0.000 description 8
102000030623 human LEP protein Human genes 0.000 description 8
108091003235 human LEP protein Proteins 0.000 description 8
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 8
235000020824 obesity Nutrition 0.000 description 8
238000002560 therapeutic procedure Methods 0.000 description 8
239000008194 pharmaceutical composition Substances 0.000 description 7
238000006467 substitution reaction Methods 0.000 description 7
230000037396 body weight Effects 0.000 description 6
235000013861 fat-free Nutrition 0.000 description 6
238000005259 measurement Methods 0.000 description 6
102000004877 Insulin Human genes 0.000 description 5
108090001061 Insulin Proteins 0.000 description 5
230000000875 corresponding Effects 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
229920002307 Dextran Polymers 0.000 description 4
102000036849 Islet amyloid polypeptide Human genes 0.000 description 4
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
230000000051 modifying Effects 0.000 description 4
210000001124 Body Fluids Anatomy 0.000 description 3
229960002989 Glutamic Acid Drugs 0.000 description 3
108010041872 Islet amyloid polypeptide Proteins 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
210000004072 Lung Anatomy 0.000 description 3
235000004279 alanine Nutrition 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
239000010839 body fluid Substances 0.000 description 3
230000002596 correlated Effects 0.000 description 3
230000002950 deficient Effects 0.000 description 3
235000013922 glutamic acid Nutrition 0.000 description 3
239000004220 glutamic acid Substances 0.000 description 3
235000004554 glutamine Nutrition 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000000034 method Methods 0.000 description 3
238000007899 nucleic acid hybridization Methods 0.000 description 3
230000002265 prevention Effects 0.000 description 3
230000002685 pulmonary Effects 0.000 description 3
HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
210000000577 Adipose Tissue Anatomy 0.000 description 2
210000004204 Blood Vessels Anatomy 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
241000282560 Macaca mulatta Species 0.000 description 2
210000002381 Plasma Anatomy 0.000 description 2
210000002700 Urine Anatomy 0.000 description 2
239000000556 agonist Substances 0.000 description 2
230000004075 alteration Effects 0.000 description 2
230000003042 antagnostic Effects 0.000 description 2
239000005557 antagonist Substances 0.000 description 2
238000004166 bioassay Methods 0.000 description 2
229940090129 blood glucose lowering drugs Thiazolidinediones Drugs 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000002537 cosmetic Substances 0.000 description 2
230000037213 diet Effects 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
229940079593 drugs Drugs 0.000 description 2
230000035558 fertility Effects 0.000 description 2
230000002068 genetic Effects 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
239000000463 material Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
230000002335 preservative Effects 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
238000011160 research Methods 0.000 description 2
241000894007 species Species 0.000 description 2
230000002459 sustained Effects 0.000 description 2
150000001467 thiazolidinediones Chemical class 0.000 description 2
239000004474 valine Substances 0.000 description 2
230000004584 weight gain Effects 0.000 description 2
235000019786 weight gain Nutrition 0.000 description 2
229920000160 (ribonucleotides)n+m Polymers 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
HRZFUMHJMZEROT-UHFFFAOYSA-L 7681-57-4 Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
229960001230 Asparagine Drugs 0.000 description 1
229960005261 Aspartic Acid Drugs 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
210000000013 Bile Ducts Anatomy 0.000 description 1
208000010392 Bone Fractures Diseases 0.000 description 1
208000006386 Bone Resorption Diseases 0.000 description 1
241000282465 Canis Species 0.000 description 1
210000001175 Cerebrospinal Fluid Anatomy 0.000 description 1
241001227713 Chiron Species 0.000 description 1
229940107161 Cholesterol Drugs 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
229940030606 DIURETICS Drugs 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
206010058108 Dyslipidaemia Diseases 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
229940088598 Enzyme Drugs 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
210000003743 Erythrocytes Anatomy 0.000 description 1
210000002468 Fat Body Anatomy 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
229960000310 ISOLEUCINE Drugs 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
241000282567 Macaca fascicularis Species 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
230000036740 Metabolism Effects 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
210000004400 Mucous Membrane Anatomy 0.000 description 1
208000006670 Multiple Fracture Diseases 0.000 description 1
210000003205 Muscles Anatomy 0.000 description 1
102000020283 Neuropeptide receptor Human genes 0.000 description 1
108070000018 Neuropeptide receptor Proteins 0.000 description 1
210000001331 Nose Anatomy 0.000 description 1
108091005503 Nucleic proteins Proteins 0.000 description 1
229920000272 Oligonucleotide Polymers 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
206010033307 Overweight Diseases 0.000 description 1
229960005190 Phenylalanine Drugs 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229940068968 Polysorbate 80 Drugs 0.000 description 1
210000003324 RBC Anatomy 0.000 description 1
102000007312 Recombinant Proteins Human genes 0.000 description 1
108010033725 Recombinant Proteins Proteins 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
206010057362 Underdose Diseases 0.000 description 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
230000002378 acidificating Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000000240 adjuvant Effects 0.000 description 1
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
150000003862 amino acid derivatives Chemical class 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
230000002491 angiogenic Effects 0.000 description 1
230000001396 anti-anti-diuretic Effects 0.000 description 1
230000000111 anti-oxidant Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000002830 appetite depressant Substances 0.000 description 1
108010062796 arginyllysine Proteins 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
230000024279 bone resorption Effects 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
230000000271 cardiovascular Effects 0.000 description 1
210000004027 cells Anatomy 0.000 description 1
201000001883 cholelithiasis Diseases 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
230000037326 chronic stress Effects 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000002354 daily Effects 0.000 description 1
230000003247 decreasing Effects 0.000 description 1
230000003111 delayed Effects 0.000 description 1
229920003013 deoxyribonucleic acid Polymers 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000002255 enzymatic Effects 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
239000012530 fluid Substances 0.000 description 1
102000037240 fusion proteins Human genes 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000003394 haemopoietic Effects 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000002209 hydrophobic Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
102000005861 leptin receptors Human genes 0.000 description 1
108010019813 leptin receptors Proteins 0.000 description 1
239000002502 liposome Substances 0.000 description 1
238000007443 liposuction Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000035786 metabolism Effects 0.000 description 1
238000002493 microarray Methods 0.000 description 1
102000035365 modified proteins Human genes 0.000 description 1
108091005569 modified proteins Proteins 0.000 description 1
108010045030 monoclonal antibodies Proteins 0.000 description 1
102000005614 monoclonal antibodies Human genes 0.000 description 1
235000020825 overweight Nutrition 0.000 description 1
238000006213 oxygenation reaction Methods 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229920000747 poly(lactic acid) polymer Polymers 0.000 description 1
108091008117 polyclonal antibodies Proteins 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000002035 prolonged Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
230000001105 regulatory Effects 0.000 description 1
230000002441 reversible Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000003772 serotonin uptake inhibitor Substances 0.000 description 1
229940001584 sodium metabisulfite Drugs 0.000 description 1
235000010262 sodium metabisulphite Nutrition 0.000 description 1
MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000010998 test method Methods 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
210000001519 tissues Anatomy 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
200000000019 wound Diseases 0.000 description 1

MXPA/A/2001/003285A 2001-03-29 MXPA01003285A (ja)